September 1, 2020Translational Cancer ResearchOpen Access

Association between clinicopathological features and prognosis significance of PD-L1 expression in small cell lung cancer patients: a systemic review and meta-analysis

View Full Paper

Ask AI

Bookmark

Authors

ZHZongtao HuChinese Academy of Sciences LLLin LüQingdao University ZFZhenle Fei

Abstract

PD-L1 is not an important predictor of most clinicopathological features of SCLC patients, but it can predict an improved survival when using mAb or FDA approved clone specifications in IHC assays.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Hu et al. (2020) studied this question.

synapsesocial.com/papers/69d80ac53eff0c9dfaae31e2 https://doi.org/10.21037/tcr-20-1512a

View Full Paper

Ask AI

Bookmark

Abstract

PD-L1 is not an important predictor of most clinicopathological features of SCLC patients, but it can predict an improved survival when using mAb or FDA approved clone specifications in IHC assays.

Association between clinicopathological features and prognosis significance of PD-L1 expression in small cell lung cancer patients: a systemic review and meta-analysis

Abstract

Discussion

Cite This Study

Association between clinicopathological features and prognosis significance of PD-L1 expression in small cell lung cancer patients: a systemic review and meta-analysis

Abstract

Discussion

Cite This Study

Also Consider

Also Consider